Thiocyanate modulates the catalytic activity of mammalian peroxidases.
We investigated the potential role of the co-substrate, thiocyanate (SCN-), in modulating the catalytic activity of myeloperoxidase (MPO) and other members of the mammalian peroxidase superfamily (lactoperoxidase (LPO) and eosinophil peroxidase (EPO)). Pre-incubation of SCN- with MPO generates a more complex biological setting, because SCN- serves as either a substrate or inhibitor, causing diverse impacts on the MPO heme iron microenvironment. Consistent with this hypothesis, the relationship between the association rate constant of nitric oxide binding to MPO-Fe(III) as a function of SCN- concentration is bell-shaped, with a trough comparable with normal SCN- plasma levels. Rapid kinetic measurements indicate that MPO, EPO, and LPO Compound I formation occur at rates slower than complex decay, and its formation serves to simultaneously catalyze SCN- via 1e- and 2e- oxidation pathways. For the three enzymes, Compound II formation is a fundamental feature of catalysis and allows the enzymes to operate at a fraction of their possible maximum activities. MPO and EPO Compound II is relatively stable and decays gradually within minutes to ground state upon H2O2 exhaustion. In contrast, LPO Compound II is unstable and decays within seconds to ground state, suggesting that SCN- may serve as a substrate for Compound II. Compound II formation can be partially or completely prevented by increasing SCN- concentration, depending on the experimental conditions. Collectively, these results illustrate for the first time the potential mechanistic differences of these three enzymes. A modified kinetic model, which incorporates our current findings with the mammalian peroxidases classic cycle, is presented.
Tahboub
Yahya R
YR
Department of Obstetrics and Gynecology, The C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan 48201, USA.
Galijasevic
Semira
S
Diamond
Michael P
MP
Abu-Soud
Husam M
HM
D002384:Catalysis; D004305:Dose-Response Relationship, Drug; D004591:Electrophoresis, Polyacrylamide Gel; D047209:Eosinophil Peroxidase / Q000737:chemistry*; D006418:Heme / Q000737:chemistry; D006801:Humans; D006861:Hydrogen Peroxide / Q000737:chemistry; D007501:Iron / Q000737:chemistry; D007700:Kinetics; D007784:Lactoperoxidase / Q000737:chemistry*; D007962:Leukocytes / Q000201:enzymology / Q000378:metabolism; D008956:Models, Chemical; D008958:Models, Molecular; D009569:Nitric Oxide / Q000737:chemistry / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D009195:Peroxidase / Q000737:chemistry*; D011485:Protein Binding; D013053:Spectrophotometry; D013861:Thiocyanates / Q000494:pharmacology*; D013997:Time Factors
D013861:Thiocyanates; D009569:Nitric Oxide; D006418:Heme; D006861:Hydrogen Peroxide; D007501:Iron; D047209:Eosinophil Peroxidase; D007784:Lactoperoxidase; D009195:Peroxidase; C031760:thiocyanate; D010100:Oxygen